UNC: Anorexia research could clear path for new drugs
Eating disorders have been historically undertreated as psychiatric condition, but now research points to a physical condition associated with anorexia that has potential to bring new attention and drugs to the condition......»»
Need to Know: Here’s one analyst’s take on the coronavirus drugs for today and the future
Analysts at Bernstein Research in a comprehensive note discussed what approaches are worth keeping an eye on......»»
General News: Here’s one analyst’s take on the coronavirus drugs for today and the future
Analysts at Bernstein Research in a comprehensive note discussed what approaches are worth keeping an eye on......»»
Are Limited Financing Options Punishing Bio-Path Stock?
Like all developmental drug companies, Bio-Path is betting on the success of its drug candidates. Drugs that are in trials often fail, so investors need to gamble that one or more of its treatments........»»
Lam Research positioned as clear industry outperformer, says DA Davidson
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
St. Louis biotech startup makes acquisition, targets commercialization
A St. Louis biotechnology startup has acquired a local research laboratory in a move to accelerate its path to commercialization. Pluton Biosciences said Wednesday it has acquired Microbe Inotech Laboratories (MiL), a commercial research and testing.....»»
Android founder Andy Rubin"s startup Essential is shutting down, saying there is "no clear path" to deliver its new phone to customers
Android creator Andy Rubin's consumer electronics startup Essential will shutter its operations, the com.....»»
Streamlining makes Allena URIROX-2 path clear, says Roth Capital
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Marker Therapeutics has "clear path" to getting MultiAA-specific study underway
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Does intermittent fasting work? Research doesn"t have a definite answer for its long-term effects
Chalermphon Kumchai/EyeEm/Getty Images Intermittent fasting can work as a weight-loss tool, and short-term research has found that it can improve overall health for those with obesity. However, the long-term results are less clear, .....»»
How one university shifted gears to build an innovation district and fulfill its region’s talent needs
Innovation districts — located in major cities and anchored by research universities — are quickly becoming the destination locations for talent and the companies that seek that talent. Two things are clear: Cities are competing for talent, and.....»»
Exclusive: Drugmakers from Pfizer to GSK to hike U.S. prices on over 200 drugs
Drugmakers including Pfizer Inc , GlaxoSmithKline PLC and Sanofi SA are planning to hike prices on more than 200 drugs in the United States on Wednesday, according to drugmakers and data analyzed by healthcare research firm 3 Axis Advisors......»»
Major drugmakers to raise prices on more than 200 drugs
Drugmakers including Pfizer, GlaxoSmithKline and Sanofi plan to hike prices on more than 200 drugs in the United States on Wednesday, according to drugmakers and data analyzed by the health care research firm 3 Axis Advisors......»»
Major drugmakers to raise prices on more than 200 drugs
Drugmakers including Pfizer, GlaxoSmithKline and Sanofi plan to hike prices on more than 200 drugs in the United States on Wednesday, according to drugmakers and data analyzed by the health care research firm 3 Axis Advisors......»»
UNC research could lead to treatments for alcohol abuse
Researchers at UNC-Chapel Hill have made a discovery in the path to understanding alcohol consumption – and abuse – by pinpointing a specific neurological circuit that seems to govern behavior. According to new research published in the Jou.....»»
After cbdMD"s Q4 Print, Analyst Sees No "Clear Path" To Company"s Positive EBITDA Guidance
CBD company cbdMD Inc. (NYSE American: YCBD) reported fourth-quarter unaudited net sales of $9.54 million Wednesday and audited net sales for fiscal year 2019 of.....»»
Does birth control make you gain weight? Research is clear it does not
iStock When oral contraceptives first came out in 1960, the amount of estrogen and progestin was much higher than it is today. S.....»»
$50M deal could expand NanoString Technologies diagnostic test into more markets
NanoString, which creates devices for molecular diagnostics and research tools to understand diseases and develop drugs, will record more than $100 million in revenue this year......»»
Don"t time the market. But if you do, here"s when the bear may hit
The U.S. stock market has been setting new records and the economy is in a record eleventh year of expansion, so one research firm thinks a recession is due in the next two years. What that means for stocks, precisely, is a little less clear......»»
Don"t time the market. But if you do, here"s when the bear may hit
The U.S. stock market has been setting new records and the economy is in a record eleventh year of expansion, so one research firm thinks a recession is due in the next two years. What that means for stocks, precisely, is a little less clear......»»
Don"t time the market. But if you do, here"s when the bear may appear
The U.S. stock market has been setting new records and the economy is in a record eleventh year of expansion, so one research firm thinks a recession is due in the next two years. What that means for stocks, precisely, is a little less clear......»»